Recovery with ketones and antipsychotics
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests whether adding a special drink with ketones can help people recover faster while taking antipsychotic medication for early psychosis. It may be a safe way to boost brain energy and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and being treated at the PEP Clinic in Estrie.
- You have been taking your current antipsychotic medicine for at least 4 weeks.
- You can read and communicate in English or French.
- You are not pregnant, breastfeeding, or within 6 months after giving birth.
- You have not used MCT oil, ketone supplements, or a ketogenic diet in the past year.
- You do not have diabetes, pancreatitis, liver failure, or certain inherited metabolic disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans (MRI) to compare how different antipsychotic medications work in people with psychosis. The goal is to find the best treatment for each person, which could lead to more personalized care.
This trial tests whether taking “ketone ester” supplements can reduce seizures in people with drug-resistant epilepsy. It may help by changing how the brain uses energy, but you must meet several safety and diet-related conditions.
This study tests whether a ketone drink can change how the body uses energy in people with bipolar disorder. It may help understand new ways to manage the condition.
This study tests whether a special high-fat, low-carbohydrate diet (ketogenic diet) can help people who have recently been diagnosed with bipolar disorder. It may improve mood stability and overall brain health.
This trial tests how a ketone drink affects the brain in healthy middle-aged adults. It may help researchers understand if ketones can support brain function.
This trial tests whether giving a special ketone drink to patients in the ICU can reduce or treat delirium (confusion). If you or a loved one is in the ICU, this treatment might help clear up confusion faster.
Hear when a new First Episode Psychosis (FEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.